Kenneth Pienta - Chief Medical Officer, Cue Biopharma, Inc

As of March 17, 2021


Kenneth Pienta Net Worth

  • Net worth is estimated to be at least $752.94K
  • Owns at least 2,000 units of Cue Biopharma, Inc stock
  • Sold an estimated value of $509.66K in the last 3 years at Cue Biopharma, Inc

Kenneth Pienta Trading

  • Largest purchase of shares was 13,439 units , worth over $67.19K on March 17, 2021
  • Largest sale of shares was 20,274 units , worth over $306.77K on February 18, 2021
  • In total has made about 6 transactions over 3 years
  • Usually trades in January, February and March, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kenneth Pienta Mailing Address

  • Mailing address is C/o Curis, Inc. 4 Maguire Road Lexington MA 02421 MA

Cue Biopharma, Inc Insider Trading

  • The most recent transaction was 3,212 units sold on October 5, 2021 by Kerri-Ann Millar worth over $17.78K
  • In the last 4 years, insiders at Cue Biopharma, Inc sold an estimated value of $3.71M and bought an estimated value of $1.98M
  • The most active traders are Christopher Marlett, Director,  Anish Suri, PRESIDENT AND CSO,  and Daniel Passeri, CHIEF EXECUTIVE OFFICER
  • Insider trading is most common in January, with the busiest year in 2018

Cue Biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1